Trending
- Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study
- Functional deficiency of circadian regulator PER2 enhances breast cancer susceptibility and progression with immunosuppression
- ARNT Expression Patterns Hold Promise for HIF-1β Inhibition in RCC Subtypes
- Precision oncology needs precision trial design: lessons from FGFR2-rearranged cholangiocarcinoma
- Bolstering The Referral Process for CAR T-Cell Therapy in Multiple Myeloma
- Iza-Bren Yields Encouraging Activity in Extensive-Stage SCLC
- Sirexatamab Regimen May Improve PFS, OS in DKK1-High Colorectal Cancer
- A simple blood test could detect multiple cancers and reveal where they started
Thursday, August 13